Amoeba SA (FR:ALMIB) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Koppert, a leader in biological crop protection, and Amoéba, a greentech company, have signed a Memorandum of Understanding to jointly launch a groundbreaking biofungicide named AXPERA. This partnership aims to enhance sustainable agriculture by utilizing Amoéba’s innovative amoeba-based solution to combat fungal diseases. The collaboration will focus on distribution, production, and regulatory approvals, with AXPERA expected to hit the European market by the end of 2025.
For further insights into FR:ALMIB stock, check out TipRanks’ Stock Analysis page.
